Regulatory roles of junctin in sarcoplasmic reticulum calcium cycling and myocardial function.
暂无分享,去创建一个
[1] H. Drexler,et al. Reciprocal changes in the postnatal expression of the sarcolemmal Na+-Ca(2+)-exchanger and SERCA2 in rat heart. , 1995, Journal of molecular and cellular cardiology.
[2] G. Fan,et al. Junctin is a prominent regulator of contractility in cardiomyocytes. , 2007, Biochemical and biophysical research communications.
[3] F. Müller,et al. On the role of junctin in cardiac Ca2+ handling, contractility, and heart failure. , 2007, American journal of physiology. Heart and circulatory physiology.
[4] L. Jones,et al. Ca2+ binding effects on protein conformation and protein interactions of canine cardiac calsequestrin. , 1988, The Journal of biological chemistry.
[5] C. Franzini-armstrong,et al. Structural alterations in cardiac calcium release units resulting from overexpression of junctin. , 2001, Journal of molecular and cellular cardiology.
[6] N. Neff,et al. Absence of Post-translational Aspartyl β-Hydroxylation of Epidermal Growth Factor Domains in Mice Leads to Developmental Defects and an Increased Incidence of Intestinal Neoplasia* , 2002, The Journal of Biological Chemistry.
[7] G. Dorn,et al. Sarcoplasmic Reticulum Calcium Overloading in Junctin Deficiency Enhances Cardiac Contractility but Increases Ventricular Automaticity , 2007, Circulation.
[8] Peter Lipp,et al. Overexpression of junctin causes adaptive changes in cardiac myocyte Ca(2+) signaling. , 2006, Cell calcium.
[9] J. Buecker,et al. Development of Dyadic Junctional Complexes between Sarcoplasmic Reticulum and Plasmalemma in Rabbit Left Ventricular Myocardial Cells: Morphometric Analysis , 1981, Circulation research.
[10] S. Priori,et al. Abnormal Calcium Signaling and Sudden Cardiac Death Associated With Mutation of Calsequestrin , 2004, Circulation research.
[11] W. Lederer,et al. Calcium sparks and [Ca2+]i waves in cardiac myocytes. , 1996, The American journal of physiology.
[12] G. Wetzel,et al. Molecular cloning of junctin from human and developing rabbit heart. , 2000, Molecular genetics and metabolism.
[13] D. Kim,et al. cDNA cloning and characterization of human cardiac junctin. , 2000, Gene.
[14] Impaired relaxation in transgenic mice overexpressing junctin. , 2003, Cardiovascular research.
[15] V. Fuster,et al. Sudden cardiac death: mechanisms, therapies and challenges , 2005, Nature Clinical Practice Cardiovascular Medicine.
[16] D. H. Kim,et al. The asp‐rich region at the carboxyl‐terminus of calsequestrin binds to Ca2+ and interacts with triadin , 2000, FEBS letters.
[17] D. H. Kim,et al. Molecular cloning and characterization of mouse cardiac junctate isoforms. , 2001, Biochemical and biophysical research communications.
[18] Donald M. Bers,et al. Upregulated Na/Ca exchange is involved in both contractile dysfunction and arrhythmogenesis in heart failure , 2002, Basic Research in Cardiology.
[19] M. Cho,et al. Cardiac remodeling and atrial fibrillation in transgenic miceoverexpressing junctin , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[20] K. O'Neil,et al. Aspartyl β-Hydroxylase (Asph) and an Evolutionarily Conserved Isoform of Asph Missing the Catalytic Domain Share Exons with Junctin* , 2000, The Journal of Biological Chemistry.
[21] S. Priori,et al. Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death , 2006, Circulation research.
[22] E. Marbán,et al. Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle. , 1986, The Journal of clinical investigation.
[23] A. Moorman,et al. Patterns of expression of sarcoplasmic reticulum Ca(2+)-ATPase and phospholamban mRNAs during rat heart development. , 1995, Circulation research.
[24] Sandor Györke,et al. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium. , 2004, Biophysical journal.
[25] Yvonne M. Kobayashi,et al. Complex Formation between Junctin, Triadin, Calsequestrin, and the Ryanodine Receptor , 1997, The Journal of Biological Chemistry.
[26] M. Lohse,et al. Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the β1−adrenergic receptor , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] R. Gambari,et al. Myocyte Enhancer Factor 2 Activates Promoter Sequences of the Human AβH-J-J Locus, Encoding Aspartyl-β-Hydroxylase, Junctin, and Junctate , 2005, Molecular and Cellular Biology.
[28] R. Gambari,et al. Molecular Cloning, Expression, Functional Characterization, Chromosomal Localization, and Gene Structure of Junctate, a Novel Integral Calcium Binding Protein of Sarco(endo)plasmic Reticulum Membrane* , 2000, The Journal of Biological Chemistry.
[29] L. Jones,et al. Purification, Primary Structure, and Immunological Characterization of the 26-kDa Calsequestrin Binding Protein (Junctin) from Cardiac Junctional Sarcoplasmic Reticulum (*) , 1995, The Journal of Biological Chemistry.
[30] CharlesAntzelevitch,et al. Cellular Mechanisms Underlying the Development of Catecholaminergic Ventricular Tachycardia , 2005 .
[31] DaweiJiang,et al. Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (Ryanodine Receptor) Mutant Associated With Ventricular Tachycardia and Sudden Death , 2002 .
[32] P. Kirchhof,et al. Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin. , 2004, American journal of physiology. Heart and circulatory physiology.
[33] C. Antzelevitch,et al. Cellular Mechanisms Underlying the Development of Catecholaminergic Ventricular Tachycardia , 2005, Circulation.
[34] S. Priori,et al. Clinical Phenotype and Functional Characterization of CASQ2 Mutations Associated With Catecholaminergic Polymorphic Ventricular Tachycardia , 2006, Circulation.